Genpact Limited G
Composite 63/100; the shares have moved about 39% annualised. Names that move more contribute more risk for the same amount invested, and our composite reflects how strong the evidence for this one is right now.
Momentum ranks 35/100 — a moderate mark against it.
Valuation ranks 76/100 — a strong point in its favour. Balance-sheet strength ranks 75/100 — a strong point in its favour. Quality ranks 63/100 — a moderate point in its favour.
Momentum ranks 35/100 — a moderate mark against it.
What the company does Genpact provides business process and IT services across financial services, consumer/healthcare, and high-tech manufacturing. Its offerings include loan operations, customer experience, supply-chain management, regulatory compliance, and AI-driven analytics.
Key financials Genpact posts ROE 23.1%, ROA 9.2%, and ROCE 18.6%. Margins: gross 36.3%, operating 15.4%, net 11.0%. Revenue grew 6.7% and EPS 17.8%. Debt/equity is 0.71, net debt/EBITDA 0.96, interest coverage 10.13x, current ratio 1.69.
Stock health Overall Sideravia score 60.6 (average quality, attractive valuation, weak momentum). Quality 58.8, Growth 45.2, Strength 72.7, Valuation 84.3, Momentum 26.1, Income 76.4. RSI(14) 67.50; 12-month return –20.66%.
Price vs fair value The stock trades at a discount of 132.10% versus our fair-value estimate and a discount of 11.16% versus the analyst 12-month target. - Fair-value discount reflects deep undervaluation vs. peers (Valuation percentile 84.3). - Recent AI coverage highlights potential upside but lacks near-term catalysts (Insider Monkey, 2026-07-31). - Comparable AI-services names showing momentum (TaskUs +5.1%, Zacks 2026-07-28). - Analysts debate AI positioning vs. peers like Innodata (Zacks 2026-07-27). - Screened as an LBO candidate, which can support valuation (24/7 Wall St. 2026-07-27).
Looking forward Forward P/E 18.32 implies earnings recovery; FCF yield 11.9% supports cash returns. Dividend yield 2.3% with 21.4% payout offers modest income. Growth remains challenged (Growth score 45.2), so execution on AI and margin expansion will be key.
This is not investment advice. Sideravia provides automated, data-driven analysis for information and education only. Nothing on this page is a personal recommendation or an invitation to buy or sell any security, and it does not consider your objectives or financial situation. Assessments are generated by rules applied uniformly to every covered stock — how our scores work.
Data as of 2026-09-05, compiled from third-party sources; errors and delays are possible and figures are not warranted. Investing puts your capital at risk; past performance does not predict future results. We publish our full track record, including the calls that lost, and our conflicts of interest.